Provider QP49-21 Update for New to Market Medical Drugs: Anifrolumab, Teplizumab, Donislecel, and Difelikefalin Read More
Provider QP48-21 Learn to Live – An Online Behavioral Health Resource for Select Blue Cross and Blue Shield of Minnesota Health Plan Members Read More
Provider QP50-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective August 1, 2021 Read More
Provider QP51-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 25, 2021 Read More
Provider QP47-21 Audio-Only Telehealth Visits do not Meet Requirements for Risk Adjustment Face-to-Face Requirement Read More
Provider P36-21 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update Read More
Provider P34-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 2, 2021 Read More
Provider P3R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers Read More